Medicinal Products

Keytruda

Name Keytruda
Active Substance pembrolizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC18
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Knjižica s čestim pitanjima za zdravstvene radnike, verzija 5
Educational materials
for patients / caregivers
Knjižica s informacijama za bolesnika, verzija 5
Kartica s upozorenjima za bolesnika, verzija 5

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/keytruda

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o ograničenju indikacije lijeka Keytruda (pembrolizumab) 10.07.2018 Merck Sharp & Dohme B. V.
Back